Cargando…

β-Lapachone Selectively Kills Hepatocellular Carcinoma Cells by Targeting NQO1 to Induce Extensive DNA Damage and PARP1 Hyperactivation

Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death globally. Currently there is a lack of tumor-selective and efficacious therapies for hepatocellular carcinoma. β-Lapachone (ARQ761 in clinical form) selectively kill NADPH: quinone oxidoreductase 1 (NQO1)-overexpressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Wenxiu, Jiang, Lingxiang, Fang, Ting, Fang, Fei, Liu, Yingchun, Zhao, Ye, You, Yuting, Zhou, Hao, Su, Xiaolin, Wang, Jiangwei, Liu, Sheng, Chen, Yaomin, Wan, Jun, Huang, Xiumei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8523939/ https://www.ncbi.nlm.nih.gov/pubmed/34676172 http://dx.doi.org/10.3389/fonc.2021.747282

Ejemplares similares

KP372-1-Induced AKT Hyperactivation Blocks DNA Repair to Synergize With PARP Inhibitor Rucaparib via Inhibiting FOXO3a/GADD45α Pathway
por: Jiang, Lingxiang, et al.
Publicado: (2022)

NQO1 is Required for β-Lapachone-Mediated Downregulation of Breast-Cancer Stem-Cell Activity
por: Kim, Dong Wook, et al.
Publicado: (2018)

β-lapachone ameliorates murine cisplatin nephrotoxicty – NAD+, NQO1, and SIRT1 at the crossroads of metabolism, injury, and inflammation
por: Lu, Christopher Y.
Publicado: (2014)

β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
por: Yang, Yang, et al.
Publicado: (2017)

β-Lapachone Induces Acute Oxidative Stress in Rat Primary Astrocyte Cultures that is Terminated by the NQO1-Inhibitor Dicoumarol
por: Steinmeier, Johann, et al.
Publicado: (2020)

XRCC1 Mutation is Associated with PARP1 Hyperactivation and Cerebellar Ataxia
por: Hoch, Nicolas, et al.
Publicado: (2016)

Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone
por: Chakrabarti, Gaurab, et al.
Publicado: (2015)

Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
por: Gerber, David E., et al.
Publicado: (2018)

NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
por: Li, Xiaoguang, et al.
Publicado: (2019)

Arylamino-nor-β-lapachone derivative-induced apoptosis in human prostate cancer cells: involvement of NAD(P)H:quinone oxidoreductase (NQO1)
por: Cavalcanti, Bruno C, et al.
Publicado: (2013)

DNA damage induced by KP372-1 hyperactivates PARP1 and enhances lethality of pancreatic cancer cells with PARP inhibition
por: Viera, Talysa, et al.
Publicado: (2020)

Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
por: Chakrabarti, Gaurab, et al.
Publicado: (2015)

β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells
por: Park, E J, et al.
Publicado: (2014)

Hyperactivation of PARP Triggers Nonhomologous End-Joining in Repair-Deficient Mouse Fibroblasts
por: Gassman, Natalie R., et al.
Publicado: (2012)

Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation
por: Li, Guan-Nan, et al.
Publicado: (2022)

X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone –induced apoptosis in pancreatic cancer cells
por: Zheng, Yansong, et al.
Publicado: (2021)

Redox modulation of NQO1
por: Siegel, David, et al.
Publicado: (2018)

Synergistic Effect of β-Lapachone and Aminooxyacetic Acid on Central Metabolism in Breast Cancer
por: Chang, Mario C., et al.
Publicado: (2022)

PARP1 Deficiency Reduces Tumour Growth by Decreasing E2F1 Hyperactivation: A Novel Mechanism in the Treatment of Cancer
por: Iglesias, Pablo, et al.
Publicado: (2020)

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.
por: Ross, D., et al.
Publicado: (1996)

DNA Damage in Nijmegen Breakage Syndrome Cells Leads to PARP Hyperactivation and Increased Oxidative Stress
por: Krenzlin, Harald, et al.
Publicado: (2012)

Implications of NQO1 in cancer therapy
por: Oh, Eun-Taex, et al.
Publicado: (2015)

The Role of NQO1 in Ovarian Cancer
por: Tossetta, Giovanni, et al.
Publicado: (2023)

Anticancer Potential of Resveratrol, β-Lapachone and Their Analogues
por: Ferraz da Costa, Danielly C., et al.
Publicado: (2020)

Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1
por: Salido, Eduardo, et al.
Publicado: (2022)

Activation of NQO1 in NQO1*2 polymorphic human leukemic HL-60 cells by diet-derived sulforaphane
por: Wu, Joseph M., et al.
Publicado: (2016)

De-novo NAD(+) synthesis regulates SIRT1-FOXO1 apoptotic pathway in response to NQO1 substrates in lung cancer cells
por: Liu, Huiying, et al.
Publicado: (2016)

Associations of NQO1 C609T and NQO1 C465T polymorphisms with acute leukemia risk: a PRISMA-compliant meta-analysis
por: He, Hairong, et al.
Publicado: (2017)

NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation: NQO1/CPT1A promotes PAAD via FAO
por: Xu, Ran, et al.
Publicado: (2023)

NQO1 Binds and Supports SIRT1 Function
por: Tsvetkov, Peter, et al.
Publicado: (2021)

NQO1 protects against clioquinol toxicity
por: Chhetri, Jamuna, et al.
Publicado: (2022)

The possibility of low isomerization of β-lapachone in the human body
por: Lee, Kyung Min, et al.
Publicado: (2021)

The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1
por: Flick, Hollie E., et al.
Publicado: (2013)

Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
por: Torrente, Laura, et al.
Publicado: (2020)

LncRNA Nqo1-AS1 Attenuates Cigarette Smoke-Induced Oxidative Stress by Upregulating its Natural Antisense Transcript Nqo1
por: Zhang, Haiyun, et al.
Publicado: (2021)

Clinical implications of high NQO1 expression in breast cancers
por: Yang, Yang, et al.
Publicado: (2014)

Contributions of PARP‐1 rs1136410 C>T polymorphism to the development of cancer
por: Li, Hunian, et al.
Publicado: (2020)

Enhancement of radiation effect using beta-lapachone and underlying mechanism
por: Ahn, Ki Jung, et al.
Publicado: (2013)

Antibacterial and Antibiofilm Activities of β-Lapachone by Modulating the Catalase Enzyme
por: Mir, Mushtaq Ahmad, et al.
Publicado: (2023)

In vitro effects of lapachol and β-lapachone against Leishmania amazonensis
por: Ramos-Milaré, Á.C.F.H., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vjmkesjgb3v1uq6kbdvopo6vtl